Product Information
PALIPERIDONE ER 1.5 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.7658 per EA under NDC 43975034903. Its NADAC has been published 321 times since May 6, 2020.
Strength
1.5 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
43975034903
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PALIPERIDONEApproval Type
Generic (ANDA)
FDA Application
ANDA204452On Market Since
11/27/2019
Pharmacological Classes
Price Statistics
The NADAC for PALIPERIDONE ER 1.5 MG TABLET has been published 321 times since May 6, 2020, and over the history we have for it it has declined 89.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7658 per EA |
|---|---|
| All-time high | $8.7151 (Jul 15, 2020) |
| All-time low | $0.7658 (Jun 17, 2026) |
| 52-week high | $1.1179 |
| 52-week low | $0.7658 |
| Median price | $1.8514 |
| Average price | $3.2392 |
| Largest weekly change | +46.9% (Oct 19, 2022) |
| Weeks tracked | 321 |
| Tracking since | May 6, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PALIPERIDONE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PALIPERIDONE ER 1.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PALIPERIDONE ER 1.5 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.7658 per EA (NDC 43975034903), effective Jun 24, 2026.
How has the price of PALIPERIDONE ER 1.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PALIPERIDONE ER 1.5 MG TABLET has declined 89.9%. It has been tracked across 321 weekly CMS publications since May 6, 2020.
What are the highest and lowest recorded NADAC prices for PALIPERIDONE ER 1.5 MG TABLET?
Since May 6, 2020, the NADAC for PALIPERIDONE ER 1.5 MG TABLET has ranged from a low of $0.7658 (Jun 17, 2026) to a high of $8.7151 (Jul 15, 2020), with a median of $1.8514 per EA.
Are there cheaper alternatives to PALIPERIDONE ER 1.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PALIPERIDONE ER 1.5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PALIPERIDONE ER 1.5 MG TABLET?
PALIPERIDONE ER 1.5 MG TABLET (NDC 43975034903) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification